Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)

China · Delayed Price · Currency is CNY

35.47

-0.81 (-2.23%)

May 20, 2026, 12:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Manufacturing	3.97B	3.71B	3.15B	3.38B	3.00B
Pharmaceutical Manufacturing Growth	7.17%	17.69%	-6.85%	12.74%	12.02%
Medical Devices	379.94M	305.41M	215.56M	100.44M	58.88M
Medical Devices Growth	24.40%	41.68%	114.63%	70.56%	-3.39%
Total	4.35B	4.01B	3.37B	3.48B	3.06B
Total Growth	8.48%	19.22%	-3.35%	13.85%	11.68%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	4.35B	4.01B	3.37B	3.48B	3.06B
China Growth	8.48%	19.22%	-3.35%	13.85%	11.68%
Total	4.35B	4.01B	3.37B	3.48B	3.06B
Total Growth	8.48%	19.22%	-3.35%	13.85%	11.68%

Source: S&P Global Market Intelligence.